Hypoxia-enhanced Blood-Brain Barrier Chip recapitulates human barrier function and shuttling of drugs and antibodies
Чип гематоэнцефалического барьера, усиленный гипоксией, воспроизводит функции человеческого барьера и перенос лекарственных препаратов и антител
2019-06-13
SCID: 54.1/ahnk5jy6
Discuss with AI
blood-brain barrier chipdrug and antibody transcytosishypoxic differentiationinduced pluripotent stem cell-derived endotheliummicrofluidic organ-on-a-chip
Figures from the paper
Abstract (AI)
Abstract The high selectivity of the human blood-brain barrier (BBB) restricts delivery of many pharmaceuticals and therapeutic antibodies to the central nervous system. Here, we describe an in vitro microfluidic organ-on-a-chip BBB model lined by induced pluripotent stem cell-derived human brain microvascular endothelium interfaced with primary human brain astrocytes and pericytes that recapitulates the high level of barrier function of the in vivo human BBB for at least one week in culture. The endothelium expresses high levels of tight junction proteins and functional efflux pumps, and it displays selective transcytosis of peptides and antibodies previously observed in vivo. Increased barrier functionality was accomplished using a developmentally-inspired induction protocol that includes a period of differentiation under hypoxic conditions. This enhanced BBB Chip may therefore represent a new in vitro tool for development and validation of delivery systems that transport drugs and therapeutic antibodies across the human BBB.
Key Findings
1
A microfluidic BBB organ-on-a-chip uses iPSC-derived human brain microvascular endothelium with primary human astrocytes and pericytes.
2
Hypoxic differentiation within a developmentally inspired induction protocol enhances BBB barrier functionality.
3
The BBB Chip selectively transcytoses peptides and antibodies previously observed to cross the BBB in vivo, supporting drug-delivery development.
4
The engineered endothelium expresses high levels of tight-junction proteins and functional efflux pumps.
5
The model recapitulates the high selectivity and barrier function of the human in vivo BBB for at least one week in culture.
Research Object
Hypoxia-enhanced human blood-brain barrier organ-on-a-chip lined with iPSC-derived brain microvascular endothelium and interfaced with human astrocytes and pericytes
Research Subject
Human BBB barrier function and selective transcytosis/shuttling of drugs, peptides, and therapeutic antibodies under hypoxic differentiation conditions
Publication Details
Publication Date
2019-06-13
Journal
Publisher
ISSN
Cited by
602
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
Cited by5
Extracellular vesicles through the blood–brain barrier: a review2022
Design and Validation of a Human Brain Endothelial Microvessel-on-a-Chip Open Microfluidic Model Enabling Advanced Optical Imaging2020
Organ-on-a-Chip Approach for Accelerating Blood–Brain Barrier Nanoshuttle Discovery2024
Organs-on-Chips in Drug Development: Engineering Foundations, Artificial Intelligence, and Clinical Translation2026
Generation of a perfusable three-dimensional human neurovascular chip to model brain drug delivery and immune cell extravasation2025